HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Vise Technologies Inc.

Vise Technologies Inc. grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 195.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 5,407 shares of the company's stock after acquiring an additional 3,580 shares during the quarter. Vise Technologies Inc.'s holdings in HCA Healthcare were worth $1,623,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the stock. Congress Wealth Management LLC DE lifted its position in HCA Healthcare by 3.4% in the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after purchasing an additional 34 shares during the period. Evergreen Private Wealth LLC boosted its stake in shares of HCA Healthcare by 0.3% in the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock valued at $3,838,000 after buying an additional 35 shares in the last quarter. Mediolanum International Funds Ltd grew its holdings in HCA Healthcare by 0.3% during the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock worth $3,153,000 after acquiring an additional 36 shares during the period. Prairie Wealth Advisors Inc. boosted its position in shares of HCA Healthcare by 6.1% during the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock worth $210,000 after purchasing an additional 40 shares in the last quarter. Finally, Whittier Trust Co. increased its holdings in shares of HCA Healthcare by 3.6% in the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock valued at $359,000 after purchasing an additional 41 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Up 0.6%

Shares of HCA traded up $2.11 during midday trading on Tuesday, reaching $378.70. 996,914 shares of the company were exchanged, compared to its average volume of 1,440,094. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company has a market cap of $91.11 billion, a price-to-earnings ratio of 17.24, a P/E/G ratio of 1.10 and a beta of 1.46. The stock has a 50-day moving average price of $347.60 and a 200-day moving average price of $329.28.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. The company had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The business's quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the firm posted $5.36 earnings per share. Research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date is Monday, June 16th. HCA Healthcare's payout ratio is currently 12.81%.

Insider Activity at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer now owns 12,646 shares in the company, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.30% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. Barclays reduced their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a report on Monday, January 27th. Royal Bank of Canada reduced their target price on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Monday, April 28th. Baird R W downgraded HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Finally, Robert W. Baird restated a "neutral" rating and issued a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. One research analyst has rated the stock with a sell rating, six have given a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, HCA Healthcare presently has a consensus rating of "Moderate Buy" and an average target price of $381.13.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.